Identifying risk factors for early progression toward severe disease and/or mortality is fundamental for the practical management of COVID-19 patients. Evidence shows that pro-inflammatory cytokines play a pivotal role in the pathophysiology of lung damage in patients affected by coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2).
Interleukin-6 as prognosticator in patients with COVID-19 / Grifoni, Elisa; Valoriani, Alice; Cei, Francesco; Lamanna, Roberta; Gelli, Anna Maria Grazia; Ciambotti, Benedetta; Vannucchi, Vieri; Moroni, Federico; Pelagatti, Lorenzo; Tarquini, Roberto; Landini, Giancarlo; Vanni, Simone; Masotti, Luca. - In: JOURNAL OF INFECTION. - ISSN 0163-4453. - ELETTRONICO. - 81:(2020), pp. 452-482. [10.1016/j.jinf.2020.06.008]
Interleukin-6 as prognosticator in patients with COVID-19
Grifoni, Elisa;Valoriani, Alice;Cei, Francesco;Gelli, Anna Maria Grazia;Ciambotti, Benedetta;Vannucchi, Vieri;Tarquini, Roberto;Landini, Giancarlo;Vanni, Simone;Masotti, Luca
2020
Abstract
Identifying risk factors for early progression toward severe disease and/or mortality is fundamental for the practical management of COVID-19 patients. Evidence shows that pro-inflammatory cytokines play a pivotal role in the pathophysiology of lung damage in patients affected by coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2).
| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS0163445320303881.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
4.16 MB
Formato
Adobe PDF
|
4.16 MB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
